Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.

Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe,Prof Frank Sullivan,Dr Utkarsh Agrawal,Dr Daniel Morales,Prof Colin McCowan,Prof Brian Lipworth

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology（2023）

引用 0|浏览0

暂无评分

摘要

The role of INCS in COVID-19 is still unclear, but exposure to INCS does not adversely affect COVID-19 mortality. Further studies are needed to explore the association between their use and inflammatory activation, viral load, ACE2 gene expression, and outcomes, exploring different types and doses of INCS.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要